Kyle Piskel
Chief Financial Officer at Adaptive Biotechnologies · 10 reported transactions in 1 company · latest trade May 18, 2026
Their trades
Sold | May 18, 2026 | May 18, 2026 close $12.71 → Oct 29, 2026 close $28.17. S&P 500 +4.6% over the same days. | ||
Sold | Feb 4, 2026 | Feb 4, 2026 close $17.30 → Oct 29, 2026 close $28.17. S&P 500 +12.6% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $18.26 → Oct 29, 2026 close $28.17. S&P 500 +11.1% over the same days. | ||
Sold | Nov 28, 2025 | Nov 28, 2025 close $19.66 → Oct 29, 2026 close $28.17. S&P 500 +13.0% over the same days. | ||
Sold | Nov 17, 2025 | Nov 17, 2025 close $13.71 → Oct 29, 2026 close $28.17. S&P 500 +16.0% over the same days. |
$40.6K
May 18, 2026 close $12.71 → Oct 29, 2026 close $28.17. S&P 500 +4.6% over the same days.
$39.6K
Feb 4, 2026 close $17.30 → Oct 29, 2026 close $28.17. S&P 500 +12.6% over the same days.
$77.2K
Jan 12, 2026 close $18.26 → Oct 29, 2026 close $28.17. S&P 500 +11.1% over the same days.
$3.17M
Nov 28, 2025 close $19.66 → Oct 29, 2026 close $28.17. S&P 500 +13.0% over the same days.
$3.3K
Nov 17, 2025 close $13.71 → Oct 29, 2026 close $28.17. S&P 500 +16.0% over the same days.